Results 131 to 140 of about 1,603 (142)

BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients

Leukemia, 2010
Rocco Piazza, Sara Redaelli, Ilaria Iacobucci   +2 more
exaly  

Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins

Oncogene, 1999
Paris A Skourides, Ruibao Ren, Ren Ruibao   +2 more
exaly  

Regulation of the c-Abl and Bcr–Abl tyrosine kinases

Nature Reviews Molecular Cell Biology, 2004
Oliver Hantschel, Giulio Superti-Furga, Hantschel Oliver   +2 more
exaly  

BCR-ABL Inhibitor

2020
openaire   +1 more source

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

Lancet, The, 2002
Nikolas Von Bubnoff, Christian Peschel, Justus Duyster   +2 more
exaly  

Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia

Nature Reviews Cancer, 2005
Ruibao Ren, Ren Ruibao
exaly  

Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia

Oncogene, 2005
Xiaoyang Ling, Shanhai Xie, John W Belmont   +2 more
exaly  

The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells

EMBO Journal, 2002
Agata Klejman, Artur Slupianek, Thomas E Smithgall   +2 more
exaly  

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

Blood Cells, Molecules, and Diseases, 1997
Carlo Gambacorti-Passerini, Philipp Le Coutre, Luca Mologni   +2 more
exaly  

Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amine

European Journal of Medicinal Chemistry, 2015
Yuanyuan Shan, Jinyun Dong, Xiaoyan Pan   +2 more
exaly